✦ LIBER ✦
92 DOSE RANGING PHASE 2 STUDY OF BOTOX® (ONABOTULINUMTOXINA) IN IDIOPATHIC OAB: BENEFIT RISK ASSESSMENT
✍ Scribed by C.R. Chappie; R. Dmochowski; V. Nitti; M. Chancellor; K. Everaert; C.R. Thompson; G. Daniell; J. Zhou; C. Haag-Molkenteller
- Book ID
- 119620835
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 87 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.